Abstract | BACKGROUND: PURPOSE: DATA SOURCES: MEDLINE, MICROMEDEX, the Cochrane Controlled Trials Register, and Cochrane Database of Systematic Reviews from the 1950s through June 2006. STUDY SELECTION: Randomized, controlled trials; systematic reviews of trials; and observational studies; all restricted to English-language articles. DATA EXTRACTION: Paired reviewers assessed study quality and abstracted data. The authors pooled results about optimal duration of anticoagulation. DATA SYNTHESIS: LIMITATIONS: The authors could not address all management questions, and excluded non-English-language literature. CONCLUSIONS: The strength of evidence varies across the study questions but generally is strong.
|
Authors | Jodi B Segal, Michael B Streiff, Lawrence V Hofmann, Lawrence V Hoffman, Katherine Thornton, Eric B Bass |
Journal | Annals of internal medicine
(Ann Intern Med)
Vol. 146
Issue 3
Pg. 211-22
(Feb 06 2007)
ISSN: 1539-3704 [Electronic] United States |
PMID | 17261856
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review, Systematic Review)
|
Chemical References |
- Anticoagulants
- Heparin, Low-Molecular-Weight
- Vitamin K
- Heparin
|
Topics |
- Ambulatory Care
- Anticoagulants
(economics, therapeutic use)
- Cost-Benefit Analysis
- Female
- Heparin
(economics, therapeutic use)
- Heparin, Low-Molecular-Weight
(economics, therapeutic use)
- Humans
- International Normalized Ratio
- Pregnancy
- Pregnancy Complications, Hematologic
(prevention & control, therapy)
- Pulmonary Embolism
(complications, prevention & control, therapy)
- Secondary Prevention
- Stockings, Compression
- Thromboembolism
(complications, prevention & control, therapy)
- Thrombolytic Therapy
- Vena Cava Filters
- Venous Thrombosis
(complications, prevention & control, therapy)
- Vitamin K
(antagonists & inhibitors)
|